Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU herbals non-clinical testing unnecessary with long marketing history -- working group.

This article was originally published in The Tan Sheet

Executive Summary

EU HERBALS NON-CLINICAL TESTING UNNECESSARY WITH LONG-TERM USE in humans, the European Agency for the Evaluation of Medicinal Products Ad Hoc Working Group on Herbal Medicinal Products proposes in a document released Jan. 28. "Where there is sufficient experience available in humans, single-dose and repeated dose toxicity, immunotoxicity as well as local tolerance testing of well-established herbal drug preparations is not necessary," the proposal says. "Likewise, pharmacological tests including safety pharmacology and pharmacokinetics are not necessary." The proposed guidance is intended to "facilitate mutual recognition and use of bibliographic data" for herbal preparations in the European Union. Comments are being accepted by EMEA through April.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel